Once again, we have Johnson & Johnson recall news. And once again, it’s a product sold by J&J operating unit McNeil Consumer Healthcare. The company says wood and other particles have been found in Softchews Rolaids, so it’s expanding the November Rolaids recall to include all lots of the Softchews products.
Continue reading ‘J&J Recalls Rolaids on Wood-Particle Contamination’
More drugs are hitting the recall list these days. As CNN Money reports, the number of recalls hit 1,742 last year–that’s an increase of 309 percent over 2008. “We’ve seen a trend where the last four years are among the top five for the most number of drug recalls since we began tallying recalls in 1988,” says Bowman Cox, managing editor of the Gold Sheet, a trade pub that analyzes FDA data. “That’s a meaningful development.”
Johnson & Johnson (JNJ.N) recalled more Tylenol and other over-the-counter drugs on Thursday after they were linked to a musty or moldy odor, expanding a recall the company started in January. J&J’s McNeil Consumer Healthcare unit said the latest recall involved 21 lots of medications, including Tylenol for children and adults, several forms of Benadryl allergy tablets and Motrin painkiller. But it did not say how many pieces were in each lot or give a total number of items involved. J&J spokeswoman Bonnie Jacobs said, “We do not have that information.”
Continue reading ‘J&J Recalls More Tylenol, over-the-counter drugs’
The Johnson & Johnson children’s drug recall has spawned a congressional investigation, of the company’s performance on one side and of federal regulators on the other, the Washington Post reports. Spearheading the inquiry are Reps. Edolphus Towns and Darrell Issa, who head up the House Committee on Oversight and Government reform.
Continue reading ‘J&J Children’s Drug Recall – Congressional Investigation’
Even though there are no safety issues related to AstraZeneca’s recall of 4.7 million doses of swine flu vaccine, other issues remain. In particular, the nasal spray version loses an unacceptable amount of potency while in storage. As a general rule of thumb, drugs and vaccines all lose potency over time. This is one of many reasons why vaccine potency is monitored even after doses become available for sale. There are also federal guidelines that stipulate a minimum level of potency that must be maintained.
Continue reading ‘4.7 Million Doses of Flu Vaccine Recalled by AstraZeneca’
You are currently browsing the weblog archives for the Recalls category.
Biotech Trading Signals Pharma News Biotech News